Brind.
  1. Amneal Pharmaceuticals highlighted positive study results from Kashiv BioSciences and is currently seeking FDA approval for a biosimilar product.

Amneal Pharmaceuticals acquired Kashiv BioSciences, a move Chirag Patel called pivotal for creating an end-to-end biosimilar presence.

3 reports, 1 independent Updated Sep 17
Gone quiet
Reports
3
Developments
1
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Amneal Pharmaceuticals acquired Kashiv BioSciences, a move Chirag Patel called pivotal for creating an end-to-end biosimilar presence.

Who's involved

What this event is mainly about
Chirag Patel

Keep exploring

Part of

Amneal Pharmaceuticals highlighted positive study results from Kashiv BioSciences and is currently seeking FDA approval for a biosimilar product. All 1 developments

The entities involved

  • Chirag Patel

    Head of Europe – AI & Digital Transformation at Hidden Brains, based in Munich, Germany

    Nothing else this week.

Coverage

Newest first; wire copies grouped
2 more outlets ran the same wire story